SMI
11 420,78
|
533,05
|
4,90%
|
Analysen zu SMI-Werten
25.04.23 | ABB Outperform | RBC Capital Markets | |
25.04.23 | ABB Neutral | JP Morgan Chase & Co. | |
25.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
25.04.23 | Richemont Outperform | RBC Capital Markets | |
25.04.23 | UBS Buy | Goldman Sachs Group Inc. | |
25.04.23 | Nestlé Underperform | RBC Capital Markets | |
25.04.23 | ABB Outperform | RBC Capital Markets | |
25.04.23 | UBS Sector Perform | RBC Capital Markets | |
25.04.23 | UBS Hold | Jefferies & Company Inc. | |
25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
25.04.23 | Nestlé Hold | Jefferies & Company Inc. | |
25.04.23 | ABB Buy | Goldman Sachs Group Inc. | |
25.04.23 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
24.04.23 | UBS Hold | Jefferies & Company Inc. | |
24.04.23 | UBS Sector Perform | RBC Capital Markets | |
24.04.23 | Givaudan Sell | UBS AG | |
21.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
21.04.23 | Roche Sell | Deutsche Bank AG | |
21.04.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
19.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
19.04.23 | UBS Sector Perform | RBC Capital Markets | |
19.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
18.04.23 | Roche Hold | Jefferies & Company Inc. | |
18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
18.04.23 | ABB Outperform | RBC Capital Markets | |
18.04.23 | Givaudan Underperform | Bernstein Research | |
17.04.23 | ABB Neutral | JP Morgan Chase & Co. | |
17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
17.04.23 | Givaudan Sell | UBS AG | |
17.04.23 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
14.04.23 | Givaudan Hold | Deutsche Bank AG | |
14.04.23 | Givaudan Underperform | Bernstein Research | |
13.04.23 | Richemont Buy | UBS AG | |
13.04.23 | Swiss Re Equal Weight | Barclays Capital | |
13.04.23 | Givaudan Underperform | Bernstein Research | |
13.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
13.04.23 | Givaudan Sell | UBS AG | |
13.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. |